XML 50 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Preferred Stock and Stockholders' Equity (Narrative) (Details)
12 Months Ended 17 Months Ended
Feb. 07, 2020
shares
Dec. 31, 2019
USD ($)
stock_option_plan
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Aug. 09, 2018
USD ($)
Dec. 31, 2016
shares
Dec. 31, 2012
shares
Shareholders Equity [Line Items]                
Preferred stock, shares authorized (in shares)   10,000,000 10,000,000   10,000,000      
Preferred stock, par value (in USD per share) | $ / shares   $ 0.001 $ 0.001   $ 0.001      
Preferred stock, shares outstanding (in shares)   0 0   0      
Increase in shares authorized for grant (in shares)   4,601,000 4,589,000 4,508,000        
Number of stock option plans | stock_option_plan   2            
Shares available for future grants (in shares)   8,624,000 7,726,000 7,630,000 8,624,000   7,920,000  
Total intrinsic value of options exercised | $   $ 26,600,000 $ 26,600,000 $ 22,400,000        
Fair value of options vested | $   $ 30,200,000 $ 22,600,000 $ 12,300,000        
Stock options outstanding (in shares)   23,600,000 22,826,000 20,454,000 23,600,000   17,663,000  
Aggregate purchase price | $   $ 30,975,000 $ 23,657,000          
Shares issued in net-share settlement of cashless option exercises (in shares)   1,200,000 0 0        
Employee and Director Stock Option                
Shareholders Equity [Line Items]                
Non-cash stock-based compensation expense | $   $ 29,200,000 $ 23,800,000 $ 13,400,000        
Unrecognized compensation expense | $   $ 55,000,000.0     $ 55,000,000.0      
Unrecognized compensation expense, weighted-average vesting period   2 years 5 months 23 days            
Non-employee                
Shareholders Equity [Line Items]                
Stock options outstanding (in shares)   0     0      
2012 Equity Incentive Award Plan                
Shareholders Equity [Line Items]                
Increase in shares available for issuance based on percentage of common stock outstanding   4.00%     4.00%      
Exercise price as percentage of fair value of common stock, no less than   100.00%            
Shares available for future grants (in shares)               5,300,000
2012 Equity Incentive Award Plan | Minimum                
Shareholders Equity [Line Items]                
Stock options, vesting period   1 year            
2012 Equity Incentive Award Plan | Maximum                
Shareholders Equity [Line Items]                
Stock options, vesting period   4 years            
2004 Equity Incentive Plan                
Shareholders Equity [Line Items]                
Exercise price as percentage of fair value of common stock, no less than   100.00%            
Shares available for future grants (in shares)               0
2004 Equity Incentive Plan | Minimum                
Shareholders Equity [Line Items]                
Stock options, vesting period   1 year            
2004 Equity Incentive Plan | Maximum                
Shareholders Equity [Line Items]                
Stock options, vesting period   5 years            
Common Stock | Stock Repurchase Program                
Shareholders Equity [Line Items]                
Authorized amount | $           $ 100,000,000    
Shares repurchased (in shares)   2,800,000     4,600,000      
Aggregate purchase price | $   $ 31,000,000.0     $ 54,600,000      
Cost per share (in dollars per share) | $ / shares   $ 11.14     $ 11.91      
Non-employee                
Shareholders Equity [Line Items]                
Non-cash stock-based compensation expense | $   $ 200,000 $ 0 $ 0        
Common Stock                
Shareholders Equity [Line Items]                
Shares repurchased (in shares)   2,780,000 1,807,000          
Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises (in shares)   631,000            
Subsequent event | 2012 Equity Incentive Award Plan                
Shareholders Equity [Line Items]                
Increase in shares authorized for grant (in shares) 4,600,000